You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Multiple Indication Adjuvants
SBC: BIOPROTECTION SYSTEMS CORP. Topic: CBD08105The objective of this study is to demonstrate the efficacy and broad applicability of the human immune-modulating alphaGal Adjuvant Technology for antiviral vaccine development. We will use viral vaccine candidates for the select Category A viral pathogens Zaire ebolavirus (ZEBOV, filovirus), Rift Valley fever virus (RVFV, bunyavirus), and Lassa virus (LV, arenavirus), to evaluate the adjuvant pot ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Development of a Database Management System to Enable Rapid, Efficient Assay Design for Use in Detection and Diagnosis of Human Exposure to Biological
SBC: CFD RESEARCH CORPORATION Topic: CBD07114Increases in amount and diversity of high-throughput data presents tremendous organizational and analysis challenges to researchers. Our objective in this effort is to address these challenges by designing and implementing a database management system (cipherDB) for the storage, management, analysis, and visualization of diverse biological data types. The Phase I design and implementation of ciphe ...
SBIR Phase II 2008 Department of DefenseOffice for Chemical and Biological Defense -
Development of a Field-Ready Antimicrobial Wound Dressing for the Treatment of Vesicant Burns
SBC: Stratatech Corporation Topic: CBD07113Cutaneous wounds, such as those resulting from vesicant exposure and thermal injuries, provide an ideal environment for bacterial growth and the complications stemming from wound sepsis. The availability of ready-to-use, antimicrobial skin substitutes that are readily deployed in the field would provide immediate wound closure and reduce the incidence of infection in these wounds. To address thes ...
SBIR Phase II 2008 Department of DefenseOffice for Chemical and Biological Defense -
Low-Output High Precision Automated Powder Disseminator
SBC: ADVANCED MECHANICAL SYSTEMS TECHNOLOGY, Topic: CBD06101This proposal presents a Phase II SBIR project to produce prototypes of the automated high precision, low disperse rate powder disseminator for the US Army, that has been successfully designed and analyzed in the Phase I project. In the development of the sensitive detecting agent, we need to release a precise amount of C&B agents in the controlled detection experiments. At the end of this Phase ...
SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense -
Development of a Database Management System to Enable Rapid, Efficient Assay Design for Use in Detection and Diagnosis of Human Exposure to Biological
SBC: CFD RESEARCH CORPORATION Topic: CBD07114The primary objective of this effort is to design and develop a database management system (DBMS) and enable the integrated interpretation of the vast amounts of genomic and proteomic data in proper biological context. This DBMS will enable the development of diagnostic assays for human exposure to specific biological threat agents using an existing suite of systems biology tools. The DBMS design ...
SBIR Phase I 2007 Department of DefenseOffice for Chemical and Biological Defense -
Development of a Field-Ready Antimicrobial Wound Dressing for the Treatment of Vesicant Burns
SBC: Stratatech Corporation Topic: CBD07113Cutaneous wounds, such as those resulting from vesicant exposure and thermal injuries, provide an ideal environment for bacterial growth and the complications stemming from wound sepsis. The availability of ready-to-use, antimicrobial skin substitutes that are readily deployed in the field would provide immediate wound closure and reduce the incidence of infection in these wounds. To address thes ...
SBIR Phase I 2007 Department of DefenseOffice for Chemical and Biological Defense